Low-dose daily aspirin in older adults lowers cancer risk in some, raises it in others, with one expert calling the research ...

Researchers found that 160 milligrams of daily aspirin significantly lowered cancer recurrence risk for colorectal patients ...

Aspirin's role in preventing colorectal cancer is nuanced. While high-risk individuals, including those with unhealthy ...

A Scandinavian clinical trial has revealed that low-dose aspirin can halve the risk of colon and rectal cancer recurrence in ...

The hydrogel spacer minimizes radiation exposure to the rectum, decreasing bowel, urinary, and sexual complications. Recent analysis reveals that rectal spacers significantly lower recurrence rates in ...

Most colorectal cancers start as a growth, called a polyp, on the inner lining of the colon or rectum. It may take as many as ...

A new study led by University of Manchester scientists has identified genetic variants that make some patients more sensitive ...

Low-dose aspirin may reduce risk for cancer development among older individuals with clonal hematopoiesis of indeterminate ...

Five-year cancer survival rates for each stage of cancer is lower in nonmetropolitan areas for Black and White individuals in the US.

Three presentations at ESMO 2025 will demonstrate Lunit SCOPE IO’s value in predicting immunotherapy response in colorectal, ...

Discover how rectal spacers revolutionize prostate cancer treatment by reducing side effects and enhancing radiation dose ...

Taking daily low-dose aspirin could almost halve the risk of colorectal cancer recurrence for some patients whose tumors have ...